Bent H. Hellum

478 total citations
10 papers, 389 citations indexed

About

Bent H. Hellum is a scholar working on Pharmacology, Molecular Biology and Complementary and alternative medicine. According to data from OpenAlex, Bent H. Hellum has authored 10 papers receiving a total of 389 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Pharmacology, 4 papers in Molecular Biology and 3 papers in Complementary and alternative medicine. Recurrent topics in Bent H. Hellum's work include Pharmacological Effects of Natural Compounds (7 papers), Medicinal Plants and Bioactive Compounds (4 papers) and Pharmacogenetics and Drug Metabolism (3 papers). Bent H. Hellum is often cited by papers focused on Pharmacological Effects of Natural Compounds (7 papers), Medicinal Plants and Bioactive Compounds (4 papers) and Pharmacogenetics and Drug Metabolism (3 papers). Bent H. Hellum collaborates with scholars based in Norway, China and United Kingdom. Bent H. Hellum's co-authors include Odd G. Nilsen, Zhuohan Hu, Aihua Liang, Yong Zhao, Olav Spigset, Mette Goul Thomsen and Jens Rohloff and has published in prestigious journals such as Phytotherapy Research, Planta Medica and European Journal of Clinical Pharmacology.

In The Last Decade

Bent H. Hellum

10 papers receiving 375 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Bent H. Hellum Norway	10	246	160	118	70	69	10	389
Sen Sun China	13	192 0.8×	118 0.7×	174 1.5×	69 1.0×	35 0.5×	15	394
Yinying Ba China	14	161 0.7×	73 0.5×	202 1.7×	59 0.8×	83 1.2×	22	481
Xuefeng Xiao China	16	239 1.0×	225 1.4×	285 2.4×	80 1.1×	76 1.1×	33	635
Ju-Xiu He Japan	10	206 0.8×	73 0.5×	183 1.6×	64 0.9×	79 1.1×	13	352
Xuanxuan Zhu China	12	87 0.4×	77 0.5×	209 1.8×	84 1.2×	48 0.7×	27	475
Naohiro Oshima Japan	12	122 0.5×	75 0.5×	136 1.2×	151 2.2×	94 1.4×	27	367
Tao-Fang Cheng China	14	118 0.5×	161 1.0×	270 2.3×	45 0.6×	87 1.3×	18	446
Jason W. Budzinski Canada	9	381 1.5×	307 1.9×	152 1.3×	148 2.1×	225 3.3×	10	752
Kojo Agyemang China	9	209 0.8×	124 0.8×	227 1.9×	84 1.2×	86 1.2×	11	446

Countries citing papers authored by Bent H. Hellum

Since Specialization

Citations

This map shows the geographic impact of Bent H. Hellum's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Bent H. Hellum with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Bent H. Hellum more than expected).

Fields of papers citing papers by Bent H. Hellum

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Bent H. Hellum. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Bent H. Hellum. The network helps show where Bent H. Hellum may publish in the future.

Co-authorship network of co-authors of Bent H. Hellum

This figure shows the co-authorship network connecting the top 25 collaborators of Bent H. Hellum. A scholar is included among the top collaborators of Bent H. Hellum based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Bent H. Hellum. Bent H. Hellum is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

10 of 10 papers shown

Spigset, Olav, et al.. (2017). Noncompetitive inhibition of humanCYP2C9 in vitro by a commercialRhodiola roseaproduct. Pharmacology Research & Perspectives. 5(4). 10 indexed citations

Nilsen, Odd G., et al.. (2016). In vitroinhibition of cytochrome P-450 activities and quantification of constituents in a selection of commercialRhodiola roseaproducts. Pharmaceutical Biology. 54(12). 3249–3256. 16 indexed citations

Spigset, Olav, et al.. (2015). Effect of commercial Rhodiola rosea on CYP enzyme activity in humans. European Journal of Clinical Pharmacology. 72(3). 295–300. 26 indexed citations

Zhao, Yong, Bent H. Hellum, Aihua Liang, & Odd G. Nilsen. (2015). Inhibitory Mechanisms of Human CYPs by Three Alkaloids Isolated from Traditional Chinese Herbs. Phytotherapy Research. 29(6). 825–834. 20 indexed citations

Zhao, Yong, Bent H. Hellum, Aihua Liang, & Odd G. Nilsen. (2011). TheIn VitroInhibition of Human CYP1A2, CYP2D6 and CYP3A4 by Tetrahydropalmatine, Neferine and Berberine. Phytotherapy Research. 26(2). 277–283. 45 indexed citations

Hellum, Bent H., et al.. (2009). Potentin vitroInhibition of CYP3A4 and P-Glycoprotein byRhodiola rosea. Planta Medica. 76(4). 331–338. 33 indexed citations

Hellum, Bent H., Zhuohan Hu, & Odd G. Nilsen. (2009). Trade Herbal Products and Induction of CYP2C19 and CYP2E1 in Cultured Human Hepatocytes. Basic & Clinical Pharmacology & Toxicology. 105(1). 58–63. 30 indexed citations

Hellum, Bent H. & Odd G. Nilsen. (2008). In vitroInhibition of CYP3A4 Metabolism and P‐Glycoprotein‐Mediated Transport by Trade Herbal Products. Basic & Clinical Pharmacology & Toxicology. 102(5). 466–475. 76 indexed citations

Hellum, Bent H. & Odd G. Nilsen. (2007). The in vitro Inhibitory Potential of Trade Herbal Products on Human CYP2D6‐Mediated Metabolism and the Influence of Ethanol. Basic & Clinical Pharmacology & Toxicology. 101(5). 350–358. 31 indexed citations

10.

Hellum, Bent H., Zhuohan Hu, & Odd G. Nilsen. (2006). The Induction of CYP1A2, CYP2D6 and CYP3A4 by Six Trade Herbal Products in Cultured Primary Human Hepatocytes. Basic & Clinical Pharmacology & Toxicology. 100(1). 23–30. 102 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact